Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.46 |
| ▸ | MPO | P05164 | 3/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29520482 | 0.86 | LIPG (0.56) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| SCHEMBL245188 | 0.86 | LIPG (0.56) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| SCHEMBL3070429 | 0.85 | TAAR1 (0.57) | SIGMAR1CYP3A4CYP2D6CYP2C9LIPG | |
| Water SCHEMBL28085345 | 0.84 | LIPG (0.54) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| Ammonia Solution, Strong SCHEMBL28991000 | 0.84 | LIPG (0.54) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| SCHEMBL29414141 | 0.84 | LIPG (0.54) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| Hydrogen Sulfide SCHEMBL28851632 | 0.84 | LIPG (0.54) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| SCHEMBL2049761 | 0.84 | LIPG (0.54) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| Benzene SCHEMBL3118223 | 0.84 | LIPG (0.54) | SIGMAR1CYP3A4CYP2D6CYP2C9LIPG | |
| SCHEMBL8171865 | 0.83 | CYP2D6 (0.46) | SIGMAR1CYP3A4CYP2D6CYP2C9LIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190248958-A1 | PREPARATION METHOD OF OLIGOMER ADDITIVE, OLIGOMER ADDITIVE, AND LITHIUM BATTERY | NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190248958-A1 | PREPARATION METHOD OF OLIGOMER ADDITIVE, OLIGOMER ADDITIVE, AND LITHIUM BATTERY | PCNA, SCO2, PARG | SIGMAR1 3706/4885CYP3A4 3340/4885CYP2D6 4351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.